M 5 SER 0 -3.090 -2.734 <=B
M 6 GLY 0 -2.819 -2.495 <=B
M 7 ASP 0 -3.464 -3.065 <=B
M 8 SER 7 -4.779 -5.035
M 9 ASP 2 -4.886 -4.554
M 10 GLU 3 -4.905 -4.686
M 11 ASP 10 -5.567 -6.077
M 12 LEU 11 -5.796 -6.395
M 13 LEU 6 -5.681 -5.718
M 14 LYS 7 -4.500 -4.788
M 15 ALA 18 -4.926 -6.429
M 16 VAL 8 -3.976 -4.439
M 17 ARG 6 -3.105 -3.438 <=B
M 18 LEU 13 -2.526 -3.731
M 19 ILE 19 -0.804 -2.897 <=B
M 20 LYS 6 0.700 -0.071 <=B
M 21 PHE 7 0.978 0.061 <=B
M 22 LEU 21 2.803 0.065 <=B
M 23 TYR 12 5.604 3.579 <=B
M 24 GLN 6 6.003 4.623 <=B
M 25 SER 13 6.540 4.293 <=B
M 26 ASN 20 9.783 6.358 <=B
M 27 PRO 4 11.375 9.607 <=B
M 28 PRO 4 13.448 11.441 <=B
M 29 PRO 18 13.941 10.268 <=B
M 30 ASN 5 13.421 11.303 <=B
M 31 PRO 4 13.496 11.484 <=B
M 32 GLU 6 11.639 9.610 <=B
M 33 GLY 0 11.910 10.541 <=B
M 34 THR 4 10.040 8.426 <=B
M 35 ARG 6 10.573 8.667 <=B
M 36 GLN 0 11.354 10.048 <=B
M 37 ALA 2 12.435 10.775 <=B
M 38 ARG 6 14.066 11.758 <=B
M 39 ARG 4 14.724 12.570 <=B
M 40 ASN 5 14.324 12.101 <=B
M 41 ARG 13 15.030 11.806 <=B
M 42 ARG 10 15.447 12.521 <=B
M 43 ARG 6 14.747 12.361 <=B
M 44 ARG 14 14.454 11.181 <=B
M 45 TRP 16 14.519 11.009 <=B
M 46 ARG 7 13.560 11.195 <=B
M 47 GLU 6 11.896 9.838 <=B
M 48 ARG 16 11.247 8.114 <=B
M 49 GLN 9 10.013 7.826 <=B
M 50 ARG 6 8.517 6.847 <=B
M 51 GLN 12 6.412 4.295 <=B
M 52 ILE 19 5.120 2.346 <=B
M 53 HIS 7 4.414 3.101 <=B
M 54 SER 5 2.355 1.509 <=B
M 55 ILE 16 0.719 -1.204 <=B
M 56 SER 18 -0.566 -2.571 <=B
M 57 GLU 6 -1.203 -1.755 <=B
M 58 ARG 7 -2.218 -2.768 <=B
M 59 ILE 20 -3.727 -5.598
M 60 LEU 13 -4.330 -5.327
M 61 SER 7 -4.290 -4.602
M 62 THR 13 -5.060 -5.973
M 63 TYR 18 -5.515 -6.951
M 64 LEU 7 -5.514 -5.685
M 65 GLY 0 -4.211 -3.727

Identified 44 B-Cell epitope residues out of 61 total residues